Evidence map›Paper›PMID 34281391›Full record

ArticlemBio2021

A Novel Model for Papillomavirus-Mediated Anal Disease and Cancer Using the Mouse Papillomavirus.

Simon Blaine-Sauer, Myeong-Kyun Shin, Kristina A Matkowskyj, Ella Ward-Shaw, Paul F Lambert

Open access · goldAbstract read
In one paragraph

Article in mBio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Mouse Papillomavirus Outbreak in a Research Facility.Journal of the American Association for Laboratory Animal Science : JAALAS · 2025
    Article
  5. Article
  6. Article
  7. Deficiency inJournal of virology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Simon Blaine-SauerMcArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Healthgrid.471391.9, Madison, Wisconsin, USA.
Myeong-Kyun ShinMcArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Healthgrid.471391.9, Madison, Wisconsin, USA.
Kristina A MatkowskyjDepartment of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Healthgrid.471391.9, Madison, Wisconsin, USA.
Ella Ward-ShawMcArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Healthgrid.471391.9, Madison, Wisconsin, USA.
Paul F LambertMcArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Healthgrid.471391.9, Madison, Wisconsin, USA.
University of Wisconsin–Madison · USWilliam S. Middleton Memorial Veterans Hospital · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Christian Capitini · 1985 to 2026
$142.6M
Visualizing EBV and HCMV DNA Dynamics During InfectionP01CA022443 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI WILLIAM M. SUGDEN · 1985 to 2026
$53.1M
Project 3: Modulation of the head and neck tumor immune microenvironment by targeting the TAM family of receptorsP50CA278595 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Zachary Scott Morris · 2022 to 2026
$12.5M
Project 4: Role of Receptor Tyrosine Kinase AXL in HNSCC Therapy ResistanceP50DE026787 · NIDCR · UNIVERSITY OF WISCONSIN-MADISON · PI HARARI, PAUL M · 2016 to 2020
$10.8M
Defining Drivers of HPV-associated CarcinogenesisR35CA210807 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Paul F. Lambert · 2017 to 2026
$9.2M
NCI NIH HHS P01 CA022443NCI NIH HHS P30 CA014520NCI NIH HHS P50 CA278595NCI NIH HHS R35 CA210807NIDCR NIH HHS P50 DE026787
6 · The paper itself

Abstract

Up to 95% of all anal cancers are associated with infection by human papillomavirus (HPV); however, no established preclinical model exists for high-grade anal disease and cancer mediated by a natural papillomavirus infection. To establish an infection-mediated model, we infected both immunocompromised NSG and immunocompetent FVB/NJ mice with the recently discovered murine papillomavirus MmuPV1, with and without the additional cofactors of UV B radiation (UVB) and/or the chemical carcinogen 7,12-dimethylbenz(a)anthracene (DMBA). Infections were tracked via lavages and swabs for MmuPV1 DNA, and pathology was assessed at the endpoint. Tissues were analyzed for biomarkers of viral infection and papillomavirus-mediated disease, and the localization of viral infection was investigated using biomarkers to characterize the anal microanatomical zones.

Indexed as

Disease Models, AnimalMiceAnal CanalAnimalsAnthracenesAnus NeoplasmsFemaleMaleMice, Inbred NODMice, SCIDPapillomaviridaePapillomavirus InfectionsPiperidinesSquamous Intraepithelial LesionsUltraviolet Rays3-(2,6-bis(4-fluorophenyl)-3-methylpiperidin-4-ylideneamino)-2-thioxoimidazolidin-4-one on 7,12-dimethylbenz(a)anthraceneAnthracenesPiperidinesanal cancerDMBAHPVinfectionMmuPV1mousepapillomaviruspreclinical modeltransition zone

Identifiers

PMID34281391
PMCPMC8406235
OpenAlexW3183198756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.